Contrasting benefits of different artemisinin combination therapies as first-line malaria treatments using model-based cost-effectiveness analysis-Reference-Cited by-同舟云学术

Contrasting benefits of different artemisinin combination therapies as first-line malaria treatments using model-based cost-effectiveness analysis

Published:2014-11-26 Issue:1 Volume:5 Page:
ISSN:2041-1723
Container-title:Nature Communications
language:en
Short-container-title:Nat Commun

Author:

Okell Lucy C.,Cairns Matthew,Griffin Jamie T.,Ferguson Neil M.,Tarning Joel,Jagoe George,Hugo Pierre,Baker Mark,D’Alessandro Umberto,Bousema Teun,Ubben David,Ghani Azra C.

Publisher

Springer Science and Business Media LLC

Subject

General Physics and Astronomy,General Biochemistry, Genetics and Molecular Biology,General Chemistry

Link

http://www.nature.com/articles/ncomms6606.pdf

Reference61 articles.

1. World Health Organization. WHO Guidelines for the Treatment of Malaria 2nd edn WHO Press (2010).

2. Smith, D. L., Klein, E. Y., McKenzie, F. E. & Laxminarayan, R. Prospective strategies to delay the evolution of anti-malarial drug resistance: weighing the uncertainty. Malar. J. 9, 217 (2010).

3. The malERA Consultative Group on Drugs. A research agenda for malaria eradication: drugs. PLoS Med. 8, e1000402 (2011).

4. Okell, L. C., Drakeley, C. J., Bousema, T., Whitty, C. J. & Ghani, A. C. Modelling the impact of artemisinin combination therapy and long-acting treatments on malaria transmission intensity. PLoS Med. 5, e226 (2008).

5. Cairns, M. et al. Modelling the protective efficacy of alternative delivery schedules for intermittent preventive treatment of malaria in infants and children. PLoS ONE 6, e18947 (2011).

Cited by 79 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Public health impact of current and proposed age-expanded perennial malaria chemoprevention: a modelling study;2024-08-02

2. Measuring protective efficacy and quantifying the impact of drug resistance: A novel malaria chemoprevention trial design and methodology;PLOS Medicine;2024-05-09

3. The potential of gene drive releases in malaria vector species to reduce the malaria burden in different African environments;2024-04-09

4. Semi-mechanistic population pharmacokinetic/pharmacodynamic modeling of a Plasmodium elongation factor 2 inhibitor cabamiquine for prevention and cure of malaria;Antimicrobial Agents and Chemotherapy;2023-12-14

5. Analysis of complementarities between nanomedicine and phytodrugs for the treatment of malarial infection;Nanomedicine;2023-11-13